Associations between interleukin 1 polymorphisms and susceptibility to systemic lupus erythematosus: A meta-analysis

Human Immunology

Volumn 75, Issue 1, 2014, Pages 105-112

  Song, Gwan Gyu ^a   Kim, Jae Hoon ^a   Seo, Young Ho ^a   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Lee, Young Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ALLELE; ARTICLE; ASIAN; DISEASE PREDISPOSITION; EUROPE; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 84890211336     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.09.002     Document Type: Article

References (47)

1. Lee Y.H., Nath S.K. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 2005, 118:434-443. 10.1007/s00439-005-0073-1.
2. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002, 20:S1-S13.
3. Stylianou E., Saklatvala J. Interleukin-1. Int J Biochem Cell B 1998, 30:1075-1079.
4. Nicklin M.J., Barton J.L., Nguyen M., FitzGerald M.G., Duff G.W., Kornman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 2002, 79:718-725. 10.1006/geno.2002.6751.
5. Carter D.B., Deibel M.R., Dunn C.J., Tomich C.S., Laborde A.L., Slightom J.L., et al. Purification, cloning, expression, and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990, 344:633-638. 10.1038/344633a0.
6. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993, 91:403-404.
7. Steinkasserer A., Koelble K., Sim R.B. Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN). Nucleic Acids Res 1991, 19:5095.
8. Lee Y.H., Ji J.D., Song G.G. Association between interleukin 1 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. J Rheumatol 2009, 36:12-15. [doi: 36/1/12 [pii] 10.3899/jrheum.080450].
9. Lea WI, Lee YH The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. Joint Bone Spine 2012, 79:370-374.
10. Dinarello C.A., Wolff S.M. The role of interleukin-1 in disease. New Engl J Med 1993, 328:106-113. 10.1056/NEJM199301143280207.
11. Grondal G., Gunnarsson I., Ronnelid J., Rogberg S., Klareskog L., Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18:565-570.
12. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992, 22:396-402.
13. Guasch J.F., Bertina R.M., Reitsma P.H. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 1996, 8:598-602. 10.1006/cyto.1996.0080.
14. Dominici R., Cattaneo M., Malferrari G., Archi D., Mariani C., Grimaldi L.M., et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 2002, 54:82-86. 10.1007/s00251-002-0445-9.
15. Hulkkonen J., Laippala P., Hurme M. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 2000, 11:251-255.
16. Tahmasebi Z., Akbarian M., Mirkazemi S., Shahlaee A., Alizadeh Z., Amirzargar A.A., et al. Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus. Rheumatol Int 2013, 10.1007/s00296-013-2784-2.
17. Tsai L.J., Hsiao S.H., Tsai J.J., Lin C.Y., Tsai L.M., Lan J.L. Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus. Rheumatol Int 2009, 29:1001-1011. 10.1007/s00296-009-0900-0.
18. Sanchez E., Sabio J.M., Callejas J.L., de Ramon E., Garcia-Portales R., Garcia-Hernandez F.J., et al. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus. BMC Med Genet 2006, 7:48. 10.1186/1471-2350-7-48.
19. Jonsen A., Bengtsson A.A., Sturfelt G., Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res Ther 2004, 6:R557-R562. 10.1186/ar1224.
20. Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., et al. Polymorphisms of IL-1 beta gene in Japanese patients with Sjogren's syndrome and systemic lupus erythematosus. J Rheumatol 2004, 31:720-725.
21. Parks C.G., Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Gilkeson G.S., et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004, 63:91-94.
22. Huang C.M., Wu M.C., Wu J.Y., Tsai F.J. Interleukin-1 receptor antagonist gene polymorphism in chinese patients with systemic lupus erythematosus. Clin Rheumatol 2002, 21:255-257.
23. Huang C.M., Wu M.C., Wu J.Y., Tsai F.J. Lack of association of interleukin-1 beta gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol Int 2002, 21:173-175.
24. *2) and MHC class II (DR17, DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus 1999, 8:103-108.
25. Suzuki H., Matsui Y., Kashiwagi H. Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:389-390.
26. Danis V.A., Millington M., Huang Q., Hyland V., Grennan D. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. Dis Markers 1995, 12:135-139.
27. Blakemore A.I., Tarlow J.K., Cork M.J., Gordon C., Emery P., Duff G.W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994, 37:1380-1385.
28. Tsai L.J., Lan J.L., Lin C.Y., Hsiao S.H., Tsai L.M., Tsai J.J. The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus. Tissue Antigens 2006, 68:493-501. 10.1111/j.1399-0039.2006.00704.x.
29. Kobayashi T., Ito S., Yasuda K., Kuroda T., Yamamoto K., Sugita N., et al. The combined genotypes of stimulatory and inhibitory Fc gamma receptors associated with systemic lupus erythematosus and periodontitis in Japanese adults. J Periodontol 2007, 78:467-474. 10.1902/jop.2007.060194.
30. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 2006, 27:157-161. 10.1007/s00296-006-0175-7.
31. Choi S.J., Rho Y.H., Ji J.D., Song G.G., Lee Y.H. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:166-170. [doi: kei128 [pii].10.1093/rheumatology/kei128].
32. Lee Y.H., Harley J.B., Nath S.K. Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006, 14:364-371. [doi: 5201566 [pii].10.1038/sj.ejhg.5201566].
33. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
34. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186.
35. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
36. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. [doi: 0197-2456(86)90046-2 [pii]].
37. Pontillo A., Girardelli M., Kamada A.J., Pancotto J.A., Donadi E.A., Crovella S., et al. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 2012, 45:271-278. 10.3109/08916934.2011.637532.
38. Afshari J.T., Rezaieyazdi Z., Mazhani M. Association of IL-1 beta gene polymorphism with susceptibility to systemic lupus erythematosus. Int J Rheum Dis 2008, 11:30-32.
39. Camargo J.F., Correa P.A., Castiblanco J., Anaya J.M. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004, 5:609-614. 10.1038/sj.gene.6364133.
40. Chua K.H., Lau T.P., Tee Z.Y., Tan S.Y., Liana L.H. Genetic polymorphisms of the interleukin-1 beta (IL-1(beta)) -511 and +3954 single nucleotide polymorphisms (SNPs) in Malaysian systemic lupus erythematosus (SLE) patients. J Health Sci 2009, 55:657-662.
41. Wang B., Zhu J.M., Fan Y.G., Feng C.C., Chen G.M., Chen H., et al. The association of IL1alpha and IL1beta polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis. Gene 2013, 10.1016/j.gene.2013.05.059.
42. Scuderi F., Convertino R., Molino N., Provenzano C., Marino M., Zoli A., et al. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity 2003, 36:71-77.
43. Ketlinskii S.A., Alekseeva T.G., Perumov N.D., Simbirtsev A.S. The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis. Ter Arkh 1993, 65:51-54.
44. Dripps D.J., Verderber E., Ng R.K., Thompson R.C., Eisenberg S.P. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 1991, 266:20311-20315.
45. Vamvakopoulos J., Green C., Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002, 32:2988-2996. [doi: 10.1002/1521-4141(2002010)32:10<2988::AID-IMMU2988>3.0.CO;2-9].
46. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998, 28:2598-2602. [doi: 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K].
47. Witkin S.S., Gerber S., Ledger W.J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002, 34:204-209. 10.1086/338261.